“Gemcitabine and Vinorelbine: Treatment Option in Recurrent Platinum – Resistant Ovarian Cancer”. 2018. European Journal of Oncology and Environmental Health 22 (3-4): 131-37. https://mattioli1885journals.com/index.php/EJOEH/article/view/6086.